| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in AIM over the last quarter tilts toward buying: insiders added a net 125,825 shares worth roughly $24K. In the past 30 days, 1 insider bought and 0 sold. Purchases have clustered in the most recent filings.
Equels Thomas K (CEO &President) stands out among recent buyers, now holding an estimated $30K in AIM. A senior officer buying with their own money is generally read as a stronger signal than routine insider selling.
Classified under Biotechnology (Health Care sector), AIM's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 189.7K | $30.4K | +62.9K | |
| Dir | 28.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 23, 2018 | Equels Thomas K. | Executive Vice Chairman/ Ceo/ President | Buy | 112,904 | $0.31 | $35,000.24 | +21.5% | |
| Jul 23, 2018 | Springate Wayne S | Sr. VP of Operations | Buy | 32,259 | $0.31 | $10,000.29 | +99.2% | |
| Apr 27, 2018 | Equels Thomas K. | CEO, President | Buy | 32,000 | $0.32 | $10,240.00 | +6.5% | |
| Apr 27, 2018 | Appelrouth Stewart | Director | Buy | 100,000 | $0.32 | $32,000.00 | +634.9% | |
| May 2, 2017 | Rodino Peter W. III | Executive Director Govt Relations/ Secrty | Buy | 15,873 | $0.63 | $9,999.99 | New | |
| May 2, 2017 | Springate Wayne S. | Sr VP of Operations | Buy | 15,873 | $0.63 | $9,999.99 | +95.4% | |
| May 2, 2017 | Strayer David R | Chief Science/ Medical Officer | Buy | 7,937 | $0.63 | $5,000.31 | +23.4% | |
| May 2, 2017 | Pascale Adam | CFO | Buy | 15,873 | $0.63 | $9,999.99 | +137.8% | |
| Apr 27, 2017 | Equels Thomas K. | CEO, President | Buy | 72,464 | $0.69 | $50,000.16 | +17.2% | |
| Apr 11, 2017 | Equels Thomas K. | CEO, President | Buy | 200,000 | $0.50 | $100,000.00 | +90.7% |